Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPM 962 in Advanced Parkinson's Disease with L-dopa
NCT01628848Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Aug 2006
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rotigotine in Parkinson's disease (PD), sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Aug 2006; status: completed.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01628848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01628848.